Low-color-temperature light hypoglycemic lighting source, system and device

Abstract

The invention relates to the technical field of phototherapy, in particular to a low-color-temperature light hypoglycemic lighting source, system and device. The illumination light source at least comprises a first light-emitting unit used for emitting red light; and the second light emitting unit is used for emitting non-red light. According to the low-color-temperature illumination light source, system and device for reducing blood sugar through light, the first light-emitting unit and the second light-emitting unit are arranged at the same time, during illumination, only red light capable of reducing the blood sugar of a user can be emitted, only low-color-temperature illumination non-red light can be emitted, or the red light and the non-red light can be emitted at the same time, the illumination requirement can be met, and the illumination effect is improved. And the blood sugar of the user can be reduced. According to the low-color-temperature illumination light source, system and device for reducing the blood sugar through the light, the red light can be irradiated to human eyes while illumination is achieved, and the blood sugar of a user is reduced. When the blood sugar reducing device is used for reducing blood sugar, a user only needs to see a light source or work and live in the environment where the device is used for illumination, and implementation is easy.

Description

Technical Field

[0001] The present invention relates to the technical field of phototherapy, and in particular to a low-color-temperature light-lowering blood sugar illumination light source, system and device. Background Art

[0002] Hyperglycemia, medically known as hyperglycemia, refers to the level of glucose in the blood exceeding the normal range. Long-term existence in this state may cause damage to multiple key parts of the body, such as the cardiovascular system, nervous system, kidneys and eyes, and increase the risk of various related diseases.

[0003] There are two main strategies for blood sugar management: first, lifestyle adjustment, such as improving diet and increasing physical exercise, to control weight; second, drug intervention, involving the use of oral hypoglycemic drugs or insulin injections to assist in blood sugar regulation. These two methods can be used independently or in combination to achieve the best blood sugar management effect.

[0004] However, improving diet and increasing physical exercise require individuals to have a high level of self-management and self-discipline. This can be very difficult for some people, especially in a fast-paced living environment. Compared with drug therapy, controlling blood sugar through lifestyle adjustments usually takes longer to see obvious results. Even if certain results are achieved in the early stages, maintaining these healthy living habits in the long term may be a challenge. Failure to maintain a healthy lifestyle in the long term can easily lead to weight rebound or increased blood sugar levels.

[0005] In addition, although the use of drug therapy to control blood sugar is effective, it may also be accompanied by certain side effects or restrictions on use. Different types of hypoglycemic drugs have different potential adverse reactions, common ones include gastrointestinal discomfort, diarrhea, nausea and other symptoms. When choosing an appropriate drug treatment plan, the doctor will comprehensively consider the patient's specific situation to ensure the safety and effectiveness of the treatment; in other words, some patients may not be able to control blood sugar through drug treatment due to their physical condition. For example, patients with liver and kidney dysfunction may need to avoid certain drugs. And long-term reliance on drugs to control blood sugar may reduce the patient's motivation to manage blood sugar through lifestyle changes, and sometimes may lead to the development of drug tolerance.

[0006] In view of the adverse reactions that may be caused by controlling blood sugar through drug treatment, lifestyle adjustments such as improving diet and increasing physical exercise require patients to have a high degree of self-discipline. It is particularly necessary to develop a blood sugar control device that is both convenient and easy to operate. Summary of the invention

[0007] The purpose of the present invention is to overcome the problem that existing means of controlling blood sugar by adjusting lifestyle, such as diet control and exercise weight loss, are difficult to implement, and that relying on drugs to control blood sugar may have side effects or contraindications, and to provide a low color temperature light source, system and device for lowering blood sugar.

[0008] In a first aspect, the present invention provides a low color temperature light source for reducing blood sugar. The light source comprises at least: a first light emitting unit for emitting red light; and a second light emitting unit for emitting non-red light.

[0009] According to a preferred embodiment, the first light emitting unit and the second light emitting unit are driven independently, and the light emitting mode of the illumination light source is configured as follows:

[0010] In a first light-emitting mode, the first light-emitting unit in the illumination light source does not emit light, and the second light-emitting unit emits light;

[0011] A second light-emitting mode, in which the first light-emitting unit in the illumination light source emits light, and the second light-emitting unit does not emit light;

[0012] In a third light emitting mode, the first light emitting unit in the illumination light source emits light, and the second light emitting unit emits light.

[0013] According to a preferred embodiment, the light emission wavelength of the first light emitting unit is at least one wavelength between 620nm and 720nm. The light emission wavelength of the second light emitting unit is 570-620nm.

[0014] According to a preferred embodiment, in the third light-emitting mode, the minimum relative optical power value of the first light-emitting unit in the lighting source is greater than a preset optical power value. The preset optical power value is 0.3 to 0.7, in particular 0.3, 0.5, and 0.7. In the third light-emitting mode, the illumination of the first light-emitting unit is greater than the illumination of the second light-emitting unit.

[0015] According to a preferred embodiment, the continuous light emission time of the first light emitting unit does not exceed a preset time, and the preset time is 30 to 300 minutes. When the lighting source continuously emits light in the second light emission mode for a preset time, the lighting source switches from the second light emission mode to the first light emission mode. When the lighting source continuously emits light in the third light emission mode for a preset time, the lighting source switches from the third light emission mode to the first light emission mode.

[0016] According to a preferred embodiment, the color temperature of the illumination light source is configured to be 1000K-1500K, the light emission wavelength of the second light emitting unit is 590-620nm, and the ratio of the total power of the first light emitting unit to the total power of the second light emitting unit is greater than or equal to 1.1.

[0017] According to a preferred embodiment, the color temperature of the illumination light source is configured to be 1500K-2000K, the emission wavelength of the second light emitting unit is 570-590nm, and the ratio of the total power of the first light emitting unit to the total power of the second light emitting unit is greater than or equal to 1.1.

[0018] According to a preferred embodiment, the color temperature of the illumination light source is configured to be 2000K-2700K, and the color temperature of the second light emitting unit 120 is 2700K-3500K. The ratio of the total power of the second light emitting unit to the total power of the first light emitting unit is 2-10.

[0019] According to a preferred embodiment, the color temperature of the illumination light source is configured to be 2700K to 4500K, and the color temperature of the second light-emitting unit is 3500K to 5000K. The ratio of the total power of the second light-emitting unit to the total power of the first light-emitting unit is 2 to 10. In the third light-emitting mode, the proportion of blue light in the light color of the illumination light source is less than 6%, and the proportion of red light is greater than 20%.

[0020] According to a preferred embodiment, the first light-emitting unit includes at least one red LED chip. The second light-emitting unit includes at least one non-red LED chip. Wherein, in the illumination light source, the number of red LED chips provided in the first light-emitting unit is less than or equal to the number of non-red LED chips provided in the second light-emitting unit.

[0021] The present invention also provides a lighting device for lowering blood sugar with low color temperature light. The lighting device comprises at least: a light-emitting module and a wearable module. The light-emitting module is used to emit lighting light. The light-emitting module is configured with a first light-emitting unit and a second light-emitting unit; wherein the first light-emitting unit is used to emit red light; and the second light-emitting unit is used to emit non-red light. The wearable module is used to be worn. The wearable module is connected to the light-emitting module. And when a user wears the wearable module, the lighting light emitted by the light-emitting module can illuminate the user's eyes.

[0022] According to a preferred embodiment, when the light-emitting module emits light to the human eye, the light radiation intensity perceived by the human eye is less than the preset radiation intensity. Wherein, the preset radiation intensity is 700mW. When the light-emitting module emits light to the human eye, the illuminance perceived by the human eye is less than the first preset illuminance. Wherein, the value range of the first preset illuminance is 300 to 600lx.

[0023] According to a preferred embodiment, the wearable module comprises a cap body and a brim. The cap body is used to be worn by a user. The light emitting module is arranged on the brim, and the light emitting module can rotate around the brim.

[0024] According to a preferred embodiment, the wearable module comprises temples and a frame. The temples are used for being worn by a user. The light emitting module is arranged on the frame, and the light emitting module can rotate around the frame.

[0025] According to a preferred embodiment, the wearable module comprises a housing and a strap. The housing can be worn to the user's eyes through the strap. The light emitting module is arranged on the housing to project red light to the user's eyes.

[0026] According to a preferred embodiment, the wearable module comprises a mask body. The mask body can cover the user's face. The light emitting module is arranged on the mask body and is used to project red light to the human eye.

[0027] The present invention also provides a low color temperature light hypoglycemic lighting system, which at least includes a lighting fixture. The lighting fixture includes at least one of a table lamp, a ceiling lamp, a floor lamp, a spotlight, and a chandelier. The light source of the lighting fixture adopts the low color temperature light hypoglycemic lighting light source provided by the present invention.

[0028] According to a preferred embodiment, the lighting system further includes: a power module and a processing module. The power module is used to supply power to the lighting light source. The power module is configured with two power outputs, the first power output is connected to the first light-emitting unit, and the second power output is connected to the second light-emitting unit. The processing module is used to adjust the light-emitting mode of the lighting light source. The processing module adjusts the light-emitting mode of the lighting light source by controlling the current output parameters of the power module.

[0029] According to a preferred embodiment, when the first light emitting unit emits light, the illuminance of the first light emitting unit is greater than or equal to a second preset illuminance, wherein the second preset illuminance is greater than or equal to 300 lx.

[0030] Compared with the prior art, the present invention has the following beneficial effects:

[0031] The low color temperature light hypoglycemic illumination source, system and device provided by the present invention are provided with a first light-emitting unit and a second light-emitting unit, and can emit only red light that can lower the user's blood sugar, only emit non-red light for low color temperature illumination, or emit red light and non-red light at the same time during illumination, which can meet the lighting needs and lower the user's blood sugar. The low color temperature light hypoglycemic illumination source, system and device provided by the present invention can illuminate red light to the human eye while achieving illumination, thereby lowering the user's blood sugar. When using the present invention to lower blood sugar, the user only needs to visually look at the light source or work and live in an environment where the present invention is used for illumination, which is easy to implement. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 A schematic diagram of the structure of a low color temperature light source for reducing blood sugar provided by the present invention;

[0033] Figure 2 A schematic diagram of the LED chip composition of the low color temperature light hypoglycemic illumination light source provided by the present invention;

[0034] Figure 3 A schematic diagram of a hat with low color temperature and light for lowering blood sugar provided by the present invention;

[0035] Figure 4 A schematic diagram of the glasses for lowering blood sugar with low color temperature light provided by the present invention;

[0036] Figure 5 A schematic diagram of a low color temperature light-induced blood sugar lowering eye mask provided by the present invention;

[0037] Figure 6 A schematic diagram of a low color temperature light blood sugar lowering mask provided by the present invention;

[0038] Figure 7 A schematic diagram of the spectrum of an illumination light source with a color temperature configuration of 1000K to 1500K provided by the present invention;

[0039] Figure 8 A schematic diagram of the spectrum of an illumination light source with a color temperature configuration of 1500K to 2000K provided by the present invention;

[0040] Fig. 9 A schematic diagram of the spectrum of an illumination light source with a color temperature configuration of 2000K to 2700K provided by the present invention;

[0041] Fig.10 A schematic diagram of the spectrum of an illumination light source with a color temperature configuration of 2700K to 3500K provided by the present invention.

[0042] Markings in the figure:

[0043] Light-emitting module-100, first light-emitting unit-110, red light LED chip-111, second light-emitting unit-120, non-red light LED chip-121, wearable module-200, cap body-210, brim-220, temples-230, cover shell-240, strap-250, mask body-260. DETAILED DESCRIPTION

[0044] The present invention is further described in detail below in conjunction with test examples and specific implementation methods. However, this should not be understood as the scope of the above subject matter of the present invention being limited to the following embodiments, and all technologies realized based on the content of the present invention belong to the scope of the present invention.

[0045] Unless otherwise specified, in the description of the specific embodiments of the present invention, the terms indicating the orientation or position relationship such as "up", "down", "left", "right", "center", "inside", "outside", etc. are all expressions based on the orientation or position relationship shown in the drawings, or the orientation or position relationship when the invented product / equipment / device is usually used. These terms of orientation or position relationship are only for the convenience of describing the scheme of the present invention or simplifying the description in the specific embodiments, so as to facilitate the technicians to quickly understand the scheme, rather than indicating or implying that a specific device / component / element must have a specific orientation, or be constructed and operated in a specific position relationship, and therefore cannot be understood as a limitation on the present invention.

[0046] In addition, if the terms "horizontal", "vertical", "overhanging", "parallel" and the like appear, it does not mean that the corresponding devices / components / elements are required to be absolutely horizontal or vertical or overhanging or parallel, but may be slightly tilted or have deviations. For example, "horizontal" only means that its direction is more horizontal than "vertical", and does not mean that the structure must be completely horizontal, but may be slightly tilted. Alternatively, it can be simplified to mean that the corresponding devices / components / elements are set in directions such as "horizontal", "vertical", "overhanging", "parallel", etc., and can have an error / deviation of ±10% relative to the corresponding direction setting, more preferably an error / deviation within ±8%, more preferably an error / deviation within ±6%, more preferably an error / deviation within ±5%, and more preferably an error / deviation within ±4%. As long as the corresponding device / component / element is within the error / deviation range, it can still achieve its role in the scheme of the present invention.

[0047] In addition, the expressions “first”, “second”, “third”, etc. that appear in the terms are merely descriptions used to distinguish the same or similar components and should not be understood as emphasizing or implying the relative importance of specific components.

[0048] In addition, in the description of the embodiments of the present invention, "several", "plurality" and "a number" represent at least 2. It can be any number such as 2, 3, 4, 5, 6, 7, 8, 9, and even more than 9.

[0049] In addition, in the description of the technical solution of the present invention, unless otherwise clearly specified / defined / restricted, the terms "set", "install", "connect", "connected", "provided with", "laid", and "arranged" should be understood in a broad sense, for example, it can be a fixed connection, a detachable connection, or an integral connection, and can be welding, riveting, bolting, threading, and other commonly used connection means in the field. This connection can be a mechanical connection, an electrical connection, or a communication connection; it can be a direct connection, or an indirect connection through an intermediate medium, and it can be the internal connection of two elements.

[0050] Example 1

[0051] This embodiment provides a low color temperature light source for reducing blood sugar. Figure 1 The low color temperature light source for lowering blood sugar includes at least: a first light emitting unit 110 for emitting red light; and a second light emitting unit 120 for emitting non-red light.

[0052] The red light emitted by the first light-emitting unit 110 enters from the visual window and can directly activate the photosensitive retinal ganglion cells ipRGCs (special photoreceptor cells), transmit signals through the optic nerve to a series of nerve nuclei in the hypothalamus and medulla oblongata, and finally act on the peripheral brown adipose tissue BAT through the sympathetic nerves, which can affect the metabolism of blood sugar. The red light emitted by the first light-emitting unit 110 can reduce the user's blood sugar. The non-red light emitted by the second light-emitting unit 120 can be light that meets the low color temperature lighting.

[0053] The low color temperature light hypoglycemic illumination light source provided in this embodiment is provided with a first light emitting unit 110 and a second light emitting unit 120 at the same time, and can emit only red light that can lower the user's blood sugar, only emit non-red light for low color temperature illumination, or emit red light and non-red light at the same time during illumination, which can meet the lighting needs and lower the user's blood sugar. The low color temperature light hypoglycemic illumination light source, system and device provided by the present invention can illuminate red light to the human eye while achieving illumination, thereby lowering the user's blood sugar. When using the present invention to lower blood sugar, the user only needs to visually look at the light source or work and live in an environment where the present invention is used for illumination, which is easy to implement.

[0054] When the first light-emitting unit 110 and the second light-emitting unit 120 emit light at the same time, the low color temperature light hypoglycemic illumination light source provided in this embodiment increases the proportion of red light in the illumination light perceived by the human eye by emitting red light, so that the proportion of blue light in the illumination light perceived by the human eye is reduced, achieving the blue light protection effect, and improving the visual perception of the human eye, but the human eye can still perceive blue light, which can avoid drowsiness or lack of energy due to lack of blue light. And when the first light-emitting unit 110 and the second light-emitting unit 120 emit light at the same time, the proportion of blue light in the illumination light source is low, which is conducive to promoting melatonin secretion and more conducive to regulating the human body's biological clock.

[0055] Example 2

[0056] This embodiment is a further improvement of the embodiment 1, and the repeated contents are not repeated. Preferably, the first light emitting unit 110 and the second light emitting unit 120 are driven independently, and the light emitting mode of the illumination light source is configured as follows:

[0057] In a first light-emitting mode, the first light-emitting unit 110 in the lighting source does not emit light, and the second light-emitting unit 120 emits light;

[0058] In the second light-emitting mode, the first light-emitting unit 110 in the illumination light source emits light, and the second light-emitting unit 120 does not emit light;

[0059] In the third light emitting mode, the first light emitting unit 110 in the illumination light source emits light, and the second light emitting unit 120 emits light.

[0060] Preferably, the light emission wavelength of the first light emitting unit 110 is at least one wavelength between 620nm and 720nm. The light emission wavelength of the second light emitting unit 120 is 570 to 620nm. Preferably, the second light emitting unit 120 can emit orange light. Preferably, the second light emitting unit 120 can emit yellow light. Preferably, the light emission wavelength of the second light emitting unit 120 is 570 to 590nm. Preferably, the light emission wavelength of the second light emitting unit 120 is 590 to 620nm.

[0061] Preferably, in the third light emitting mode, the minimum relative optical power value of the first light emitting unit 110 in the illumination light source is greater than a preset optical power value, wherein the preset optical power value is 0.3 to 0.7, in particular 0.3, 0.5, 0.7.

[0062] In the third lighting mode, the minimum relative optical power value of the first light emitting unit 110 in the lighting source is generally greater than 0.3. Preferably, in the third lighting mode, the minimum relative optical power value of the first light emitting unit 110 in the lighting source is greater than 0.5. Typically, in the third lighting mode, the minimum relative optical power value of the first light emitting unit 110 in the lighting source is greater than 0.7. In the third lighting mode, the illumination of the first light emitting unit 110 is greater than the illumination of the second light emitting unit 120.

[0063] Preferably, the continuous light-emitting duration of the first light-emitting unit 110 does not exceed a preset duration, and the preset duration does not exceed 30 minutes. Preferably, the preset duration is 30 to 300 minutes. When the lighting source continuously emits light in the second light-emitting mode for a preset duration, the lighting source switches from the second light-emitting mode to the first light-emitting mode. When the lighting source continuously emits light in the third light-emitting mode for a preset duration, the lighting source switches from the third light-emitting mode to the first light-emitting mode.

[0064] Preferably, the color temperature of the illumination light source is configured to be 1000K-1500K, and the light emission wavelength of the second light emitting unit 120 is 590-620nm. The ratio of the total power of the first light emitting unit 110 to the total power of the second light emitting unit 120 is greater than or equal to 1.1.

[0065] Preferably, the color temperature of the illumination light source is configured to be 1500K to 2000K, and the light wavelength of the second light emitting unit 120 is 570 to 590nm. The ratio of the total power of the first light emitting unit 110 to the total power of the second light emitting unit 120 is greater than or equal to 1.1.

[0066] Preferably, the color temperature of the illumination light source is configured to be 2000K-2700K, and the color temperature of the second light emitting unit 120 is 2700K-3500K. The ratio of the total power of the second light emitting unit 120 to the total power of the first light emitting unit 110 is 2-10.

[0067] Preferably, the color temperature of the illumination light source is configured to be 2700K to 4500K, and the color temperature of the second light emitting unit 120 is 3500K to 5000K. The ratio of the total power of the second light emitting unit 120 to the total power of the first light emitting unit 110 is 2 to 10. In the third light emitting mode, the proportion of blue light in the light color of the illumination light source is less than 6%, and the proportion of red light is greater than 20%.

[0068] Preferably, the first light emitting unit 110 includes at least one red LED chip 111. The second light emitting unit 120 includes at least one non-red LED chip 121. In the illumination light source, the number of the red LED chips 111 provided in the first light emitting unit 110 is less than or equal to the number of the non-red LED chips 121 provided in the second light emitting unit 120. Figure 2 Preferably, the illumination light source may be provided with a plurality of first light emitting units 110 and a plurality of second light emitting units 120. Preferably, the first light emitting unit 110 includes at least one red light LED chip 111, and the second light emitting unit 120 includes at least one non-red light LED chip 121. The non-red light LED chip 121 may be an orange light LED chip or a yellow light LED chip. The non-red light LED chip 121 may be an LED chip with a light emission wavelength of 590 to 620 nm or an LED chip with a light emission wavelength of 570 to 590 nm.

[0069] Preferably, the illumination light source may be composed of a first light emitting unit 110 and one or more second light emitting units 120. Preferably, the total number of red LED chips 111 on the illumination light source is less than or equal to the number of non-red LED chips 121.

[0070] Preferably, the illumination light source may be composed of a single red LED chip 111 and a single non-red LED chip 121. Preferably, the illumination light source may be composed of a single red LED chip 111 and a plurality of non-red LED chips 121. Preferably, the illumination light source may be composed of a plurality of red LED chips 111 and a plurality of non-red LED chips 121.

[0071] Example 3

[0072] The present embodiment provides a lighting device for lowering blood sugar with low color temperature light, and the present embodiment provides a lighting device for lowering blood sugar with low color temperature light. The lighting device includes at least: a light-emitting module 100 and a wearable module 200. The light-emitting module 100 is used to emit illumination light. The light-emitting module 100 is configured with a first light-emitting unit 110 and a second light-emitting unit 120; wherein the first light-emitting unit 110 is used to emit red light; and the second light-emitting unit 120 is used to emit non-red light. The wearable module 200 is used to be worn. The wearable module 200 is connected to the light-emitting module 100. And when the user wears the wearable module 200, the illumination light emitted by the light-emitting module 100 can illuminate the user's eyes.

[0073] Preferably, the light emitting module 100 in this embodiment can adopt the low color temperature light source for lowering blood sugar involved in Embodiment 1 and Embodiment 2.

[0074] Preferably, when the light emitting module 100 emits light to the human eye, the light radiation intensity perceived by the human eye is less than the preset radiation intensity. The preset radiation intensity is 700mW. When the light emitting module 100 emits light to the human eye, the illuminance perceived by the human eye is less than the first preset illuminance. The value range of the first preset illuminance is 300 to 600lx.

[0075] Preferably, see Figure 3 The lighting device can be set as a hat. The wearable module 200 includes a hat body 210 and a brim 220. The hat body 210 is used for being worn by a user. The light emitting module 100 is set on the brim 220, and the light emitting module 100 can rotate around the brim 220.

[0076] Preferably, see Figure 4 The lighting device can be set as glasses. The wearable module 200 includes a temple 230 and a frame. The temple 230 is used for the user to wear. The light emitting module 100 is set on the frame, and the light emitting module 100 can rotate around the frame.

[0077] Preferably, see Figure 5 The lighting device can be set as an eye mask. The wearable module 200 includes a cover 240 and a strap 250. The cover 240 can be worn to the user's eyes through the strap 250. The light emitting module 100 is set on the cover 240 to project red light to the human eye.

[0078] Preferably, see Figure 6 The lighting device can be set as a mask. The wearable module 200 includes a mask body 260. The mask body 260 can cover the user's face. The light emitting module 100 is set on the mask body 260 to project red light to the human eye.

[0079] Preferably, the lighting device can make the human eye perceive red light, and through the ipRGC-SON-PVN-NTS neural circuit, it affects the heat production capacity of brown adipose tissue, improves the metabolic function of human blood sugar, and lowers blood sugar. Preferably, the lighting device emits light waves of a specific band, which enter from the visual window and can directly activate the photosensitive retinal ganglion cells ipRGCs (special photoreceptor cells), transmit signals through the optic nerve to a series of nerve nuclei in the hypothalamus and medulla oblongata, and finally act on the peripheral brown adipose tissue BAT through the sympathetic nerves, which can affect the metabolic capacity of blood sugar. In addition, the red light emitted by the low color temperature light hypoglycemic lighting device can also improve retinopathy caused by hyperglycemia after entering the human eye.

[0080] Example 4

[0081] This embodiment is a further improvement on Embodiment 3. In this embodiment, the lighting device is a hat. Figure 7 The color temperature of the lighting source in this embodiment is configured to be 1000K to 1500K, the light emission wavelength of the second light emitting unit 120 is 590 to 620nm, and the light emission wavelength of the first light emitting unit 120 is set to at least one of 620 to 720nm, and is particularly preferably 620nm, 670nm and 720nm. In the third light emitting mode, the light intensity illuminance perceived by the human eye is greater than 300lx. Preferably, in the third light emitting mode, the light intensity illuminance perceived by the human eye can also be greater than 600lx, or greater than 1000lx.

[0082] The lighting system provided in this embodiment was used to test 8 people with high blood sugar. The test content is: the test persons use the lighting device provided in this embodiment for 30 minutes of irradiation starting from 9:30 pm 3 hours after dinner every day. The blood sugar changes of the test persons before and after the test are recorded. Preferably, during the test, the lighting system uses the third lighting mode, and the light intensity perceived by the human eye in the room is greater than 300lx. And the test persons take hypoglycemic drugs once a day after breakfast; the test results are shown in Table 2, and the blood sugar values ​​in the table are all fingertip blood test data, unit: mmol / L.

[0083] The test results are shown in Table 1.

[0084] Table 1:

[0085]

[0086] According to the test data in Table 1, the low color temperature light hypoglycemic lighting system provided in this embodiment can effectively lower blood sugar.

[0087] Example 5

[0088] This embodiment is a further improvement of Embodiment 3. In this embodiment, the lighting device is glasses or eye masks. Figure 8 , the color temperature of the lighting source in this embodiment is configured to be 1500K-2000K, the light emission wavelength of the second light emitting unit 120 is 570-590nm, and the light emission wavelength of the first light emitting unit 120 is set to at least one of 620-720nm, and is particularly preferably 620nm, 670nm and 720nm. In the third light emitting mode, the light intensity illuminance perceived by the human eye is greater than 300lx. Preferably, in the third light emitting mode, the light intensity illuminance perceived by the human eye can also be greater than 600lx, or greater than 1000lx.

[0089] The lighting system provided in this embodiment was used to test 9 people with high blood sugar. The test content was: the test persons used the lighting device provided in this embodiment for 30 minutes of irradiation starting from 9:30 pm 3 hours after dinner every day. The blood sugar changes of the test persons before and after the test were recorded. Preferably, during the test, the lighting system uses the third lighting mode, and the light intensity perceived by the human eye in the room is greater than 300lx. And the test persons took hypoglycemic drugs once a day after breakfast; the test results are shown in Table 2, and the blood sugar values ​​in the table are all fingertip blood test data, unit: mmol / L.

[0090] The test results are shown in Table 2.

[0091] Table 2:

[0092]

[0093] According to the test data in Table 2, the low color temperature light hypoglycemic lighting system provided in this embodiment can effectively lower blood sugar.

[0094] Example 6

[0095] This embodiment provides a low color temperature light hypoglycemic lighting system, which at least includes a lighting fixture. The lighting fixture includes at least one of a table lamp, a ceiling lamp, a floor lamp, a spotlight, and a chandelier. The light source of the lighting fixture adopts the low color temperature light hypoglycemic lighting light source involved in Embodiment 1 and Embodiment 2.

[0096] Preferably, the lighting system further comprises: a power module and a processing module. The power module is used to supply power to the lighting source. The power module is configured with two power outputs, the first power output is connected to the first light-emitting unit 110, and the second power output is connected to the second light-emitting unit 110. The processing module is used to adjust the light-emitting mode of the lighting source. The processing module adjusts the light-emitting mode of the lighting source by controlling the current output parameters of the power module.

[0097] Preferably, when the first light emitting unit 110 emits light, the illuminance of the first light emitting unit 110 is greater than or equal to a second preset illuminance, wherein the second preset illuminance is greater than or equal to 300 lx.

[0098] Preferably, the lighting system provided in this embodiment can reduce blood sugar on the basis that light waves of a specific wavelength enter from the visual window, directly activating photosensitive retinal ganglion cells ipRGCs (special photoreceptor cells), transmitting signals through the optic nerve to a series of nerve nuclei in the hypothalamus and medulla oblongata, and finally acting on the peripheral brown adipose tissue BAT through the sympathetic nerves, which can affect the metabolism of blood sugar. In addition, the red light emitted by the lighting device can not only increase the proportion of red light in the lighting light perceived by the human eye by emitting red light, but also reduce the proportion of blue light in the lighting light perceived by the human eye, thereby achieving the anti-blue light effect.

[0099] Preferably, the lighting system can make the human eye perceive red light, and through the ipRGC-SON-PVN-NTS neural circuit, affect the heat production capacity of brown adipose tissue, improve the metabolic function of human blood sugar, and reduce blood sugar. In addition, the red light emitted by the low color temperature light hypoglycemic lighting system can also improve retinopathy caused by high blood sugar after entering the human eye.

[0100] Example 7

[0101] This embodiment is a further improvement of Embodiment 6. In this embodiment, the lighting system is a desk lamp. Fig. 9 , the color temperature of the lighting source in this embodiment is configured to be 2000K~2700K, and the color temperature of the second light-emitting unit 120 is 2700K~3500K. Preferably, the second light-emitting unit 120 adopts a low color temperature white light source. The light emission wavelength of the first light-emitting unit 120 is set to at least one of 620~720nm, and particularly preferably 630nm, 670nm and 720nm. In the third light-emitting mode, the light intensity illumination perceived by the human eye is greater than 300lx. Preferably, in the third light-emitting mode, the light intensity illumination perceived by the human eye can also be greater than 600lx, or greater than 1000lx.

[0102] The lighting system provided in this embodiment was used to test 8 people with high blood sugar. The test content was as follows: the test persons stayed in a room illuminated by the lighting system provided in this embodiment for 30 minutes starting from 9:30 pm 3 hours after dinner every day. The blood sugar changes of the test persons before and after the test were recorded. Preferably, during the test, the lighting system uses the third lighting mode, and the light intensity perceived by the human eye in the room is greater than 300lx. And the test persons took hypoglycemic drugs once a day after breakfast; the test results are shown in Table 2, and the blood sugar values ​​in the table are all finger-prick blood test data, unit: mmol / L.

[0103] Table 3:

[0104]

[0105] According to the test data in Table 3, the low color temperature light hypoglycemic lighting device (floor lamp) provided in this embodiment can effectively lower blood sugar.

[0106] Example 8

[0107] This embodiment is a further improvement of Embodiment 6. In this embodiment, the lighting system is a ceiling lamp. Fig.10 , the color temperature of the lighting source in this embodiment is configured to be 2700K~4500K, and the color temperature of the second light-emitting unit 120 is 3500K~5000K. Preferably, the second light-emitting unit 120 adopts a white light source. The light emission wavelength of the first light-emitting unit 120 is set to at least one of 620~720nm, and particularly preferably 630nm, 670nm and 720nm. In the third light-emitting mode, the light intensity illumination perceived by the human eye is greater than 300lx. Preferably, in the third light-emitting mode, the light intensity illumination perceived by the human eye can also be greater than 600lx, or greater than 1000lx.

[0108] The lighting system provided in this embodiment was used to test 9 people with high blood sugar. The test content was as follows: the test persons stayed in a room illuminated by the lighting system provided in this embodiment for 30 minutes starting from 9:30 pm 3 hours after dinner every day. The blood sugar changes of the test persons before and after the test were recorded. Preferably, during the test, the lighting system uses the third lighting mode, and the light intensity perceived by the human eye in the room is greater than 300lx. And the test persons took hypoglycemic drugs once a day after breakfast; the test results are shown in Table 2, and the blood sugar values ​​in the table are all finger-prick blood test data, unit: mmol / L.

[0109] The test results are shown in Table 4.

[0110] Table 4:

[0111]

[0112] According to the test data in Table 4, the low color temperature light hypoglycemic lighting system provided in this embodiment can effectively lower blood sugar.

[0113] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A low color temperature light source for reducing blood sugar, characterized in that: At least: A first light emitting unit 110, configured to emit red light; The second light emitting unit 120 is used to emit non-red light.

2. The low color temperature light source for reducing blood sugar according to claim 1, characterized in that: The first light emitting unit 110 and the second light emitting unit 120 are driven independently, and the light emitting mode of the illumination light source is configured as follows: In a first light-emitting mode, the first light-emitting unit 110 in the illumination light source does not emit light, and the second light-emitting unit 120 emits light; A second light-emitting mode, in which the first light-emitting unit 110 in the illumination light source emits light, and the second light-emitting unit 120 does not emit light; In a third light emitting mode, the first light emitting unit 110 in the illumination light source emits light, and the second light emitting unit 120 emits light.

3. The low color temperature light source for reducing blood sugar according to claim 2, characterized in that: The light emission wavelength of the first light emitting unit 110 is at least one wavelength between 620nm and 720nm; The light emission wavelength of the second light emitting unit 120 is 570-620 nm.

4. The low color temperature light source for reducing blood sugar according to claim 3, characterized in that: In the third light-emitting mode, the minimum relative optical power value of the first light-emitting unit 110 in the illumination light source is greater than a preset optical power value; wherein the preset optical power value is 0.3 to 0.7, in particular 0.3, 0.5, and 0.7; In the third light emitting mode, the illumination of the first light emitting unit 110 is greater than the illumination of the second light emitting unit 120 .

5. The low color temperature light source for reducing blood sugar according to claim 4, characterized in that: The continuous lighting duration of the first light emitting unit 110 does not exceed a preset duration, and the preset duration is 30 to 300 minutes; When the illumination light source continues to emit light in the second light-emitting mode for a preset time, the illumination light source switches from the second light-emitting mode to the first light-emitting mode; When the illumination light source continues to emit light in the third light-emitting mode for a preset time period, the illumination light source switches from the third light-emitting mode to the first light-emitting mode.

6. The low color temperature light source for reducing blood sugar according to claim 4, characterized in that: The color temperature of the illumination light source is configured to be 1000K to 1500K, and the light emission wavelength of the second light emitting unit 120 is 590 to 620nm; A ratio of the total power of the first light-emitting unit 110 to the total power of the second light-emitting unit 120 is greater than or equal to 1.

1.

7. The low color temperature light source for reducing blood sugar according to claim 4, characterized in that: The color temperature of the illumination light source is configured to be 1500K to 2000K, and the light emission wavelength of the second light emitting unit 120 is 570 to 590nm; A ratio of the total power of the first light-emitting unit 110 to the total power of the second light-emitting unit 120 is greater than or equal to 1.

1.

8. The low color temperature light source for reducing blood sugar according to claim 4, characterized in that: The color temperature of the illumination light source is configured to be 2000K to 2700K, and the color temperature of the second light emitting unit 120 is 2700K to 3500K; The ratio of the total power of the second light emitting unit 120 to the total power of the first light emitting unit 110 is 2-10.

9. The low color temperature light source for reducing blood sugar according to claim 4, characterized in that: The color temperature of the illumination light source is configured to be 2700K to 4500K, and the color temperature of the second light emitting unit 120 is 3500K to 5000K; The ratio of the total power of the second light emitting unit 120 to the total power of the first light emitting unit 110 is 2 to 10; In the third light-emitting mode, the proportion of blue light in the light color of the illumination light source is less than 6%, and the proportion of red light is greater than 20%.

10. The low color temperature light source for reducing blood sugar according to claim 3, characterized in that: The first light emitting unit 110 includes at least one red LED chip 111; The second light emitting unit 120 includes at least one non-red LED chip 121; Wherein, in the illumination light source, the number of the red LED chips 111 provided in the first light-emitting unit 110 is less than or equal to the number of the non-red LED chips 121 provided in the second light-emitting unit 120 .

11. A low color temperature light illumination device for lowering blood sugar, characterized in that: At least: The light-emitting module 100 is used to emit illumination light; the light-emitting module 100 is configured with a first light-emitting unit 110 and a second light-emitting unit 120; wherein the first light-emitting unit 110 is used to emit red light; and the second light-emitting unit 120 is used to emit non-red light; The wearable module 200 is used for wearing; the wearable module 200 is connected to the light emitting module 100, and when the user wears the wearable module 200, the illumination light emitted by the light emitting module 100 can illuminate the user's eyes.

12. The low color temperature light-lowering blood sugar lighting device according to claim 11, characterized in that: When the light emitting module 100 emits light to human eyes, the light radiation intensity perceived by human eyes is less than a preset radiation intensity; wherein the preset radiation intensity is 700 mW; When the light emitting module 100 emits light to human eyes, the illuminance perceived by the human eyes is less than a first preset illuminance; wherein the value range of the first preset illuminance is 300-600 lx.

13. The low color temperature light-lowering blood sugar lighting device according to claim 11, characterized in that: The wearable module 200 includes a cap body 210 and a brim 220 ; the cap body 210 is used to be worn by a user, the light emitting module 100 is arranged on the brim 220 , and the light emitting module 100 can rotate around the brim 220 .

14. The low color temperature light-lowering blood sugar lighting device according to claim 11, characterized in that: The wearable module 200 includes temples 230 and a frame; the temples 230 are used for being worn by a user, the light emitting module 100 is arranged on the frame, and the light emitting module 100 can rotate around the frame.

15. The low color temperature light-lowering blood sugar lighting device according to claim 11, characterized in that: The wearable module 200 includes a cover 240 and a strap 250; the cover 240 can be worn to the user's eyes through the strap 250; The light emitting module 100 is disposed on the housing 240 to project red light to human eyes.

16. The low color temperature light-lowering blood sugar lighting device according to claim 10, characterized in that: The wearable module 200 includes a mask body 260; the mask body 260 can cover the user's face; The light emitting module 100 is disposed on the mask body 260 and is used to project red light to human eyes.

17. A low color temperature light illumination system for reducing blood sugar, characterized in that: At least: Lighting fixtures, the lighting fixtures comprising at least one of table lamps, ceiling lamps, floor lamps, spotlights, and chandeliers; The light source of the lighting fixture adopts the lighting light source as claimed in claim 1.

18. The low color temperature light hypoglycemic lighting system according to claim 18, characterized in that: The lighting system further comprises: A power supply module, used to supply power to the lighting source, wherein the power supply module is configured with two power supply outputs, a first power supply output is connected to the first light-emitting unit 110, and a second power supply output is connected to the second light-emitting unit 110; A processing module is used to adjust the light-emitting mode of the illumination light source; wherein the processing module adjusts the light-emitting mode of the illumination light source by controlling the current output parameters of the power supply module.

19. The low color temperature light hypoglycemic lighting system according to claim 18, characterized in that: When the first light emitting unit 110 emits light, the illuminance of the first light emitting unit 110 is greater than or equal to a second preset illuminance; wherein the second preset illuminance is greater than or equal to 1000 lx.

Images